The estimated Net Worth of George M Whitesides is at least $370 Tysiąc dollars as of 11 August 2017. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $32,400 and over the last 10 years he sold TBPH stock worth over $0. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc.
George has made over 1 trades of the Theravance Biopharma Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of TBPH stock worth $98,760 on 11 August 2017.
The largest trade he's ever made was buying 4,000 units of Theravance Biopharma Inc stock on 11 August 2017 worth over $98,760. On average, George trades about 364 units every 0 days since 2014. As of 11 August 2017 he still owns at least 4,000 units of Theravance Biopharma Inc stock.
You can see the complete history of George Whitesides stock trades at the bottom of the page.
Dr. George M. Whitesides Ph.D. serves as Independent Director of the Company., serves as an Independent Director of Company. Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. He has been Woodford L. and Ann A. Flowers University Professor at Harvard University since 2004. From 1986 to 2004, Dr. Whitesides was Mallinckrodt Professor of Chemistry at Harvard University. From 1982 to 1991 he was a member of the Department of Chemistry at Harvard University and Chairman of the Department of Chemistry from 1986 to 1989. He was a faculty member of the Massachusetts Institute of Technology from 1964 to 1982. Dr. Whitesides was a 1998 recipient of the National Medal of Science. He is a member of the editorial boards of 15 scientific journals. He is also a member of the board of directors of Nano Terra Inc., Arsenal Biomedical, Inc., Lyra Biomedical, Inc., Diagnostics for All, Inc. and Soft Robotics Inc. Dr. Whitesides holds a Ph.D. in Chemistry from the California Institute of Technology and a B.A. from Harvard University. . Whitesides' demonstrated leadership in his field, his knowledge of scientific matters affecting our business and his understanding of our industry contributed to our board's conclusion that he should serve as a director.
As the Independent Director of Theravance Biopharma Inc, the total compensation of George Whitesides at Theravance Biopharma Inc is $337,879. There are 18 executives at Theravance Biopharma Inc getting paid more, with Rick Winningham having the highest compensation of $5,932,410.
George Whitesides is 80, he's been the Independent Director of Theravance Biopharma Inc since 2013. There are 1 older and 26 younger executives at Theravance Biopharma Inc. The oldest executive at Theravance Biopharma Inc is Burton Malkiel, 87, who is the Independent Director.
Over the last 11 years, insiders at Theravance Biopharma Inc have traded over $11,619,559 worth of Theravance Biopharma Inc stock and bought 4,008,513 units worth $29,986,832,769,275 . The most active insiders traders include Plc Gsk, Inc. Innoviva, oraz Eli Samaha. On average, Theravance Biopharma Inc executives and independent directors trade stock every 57 days with the average trade being worth of $448,635. The most recent stock trade was executed by Eli Samaha on 7 August 2024, trading 999,800 units of TBPH stock currently worth $7,798,440.
theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.
Theravance Biopharma Inc executives and other stock owners filed with the SEC include: